Friday, May 3, 2024
ADVT 
International

White House makes clear U.S. not sharing vaccines

Darpan News Desk The Canadian Press, 02 Mar, 2021 12:05 AM
  • White House makes clear U.S. not sharing vaccines

The White House is making it abundantly clear it has no plans to share America's COVID-19 vaccines with Canada or Mexico.

Press secretary Jen Psaki has been indicating for weeks that the Biden administration would not allow the export of doses manufactured in the U.S. any time soon.

Today, with Mexico planning to explicitly ask for help, Psaki ruled the possibility out entirely.

She says President Joe Biden is focused first on making sure the vaccine is available to every American.

Mexican President Andres Manuel Lopez Obrador was expected to ask Biden directly for doses when the two meet virtually later today.

Prime Minister Justin Trudeau reportedly stopped short of making a similar request in his virtual meetings with Biden last week.

"No," Psaki said today when asked whether the U.S. would be willing to share its supply of vaccine doses.

"The president has made clear that he is focused on ensuring that vaccines are available to every American. That is our focus."

Psaki hinted last week that the White House position could change later this year once more Americans are vaccinated and the doses are no longer in such short supply.

Johnson and Johnson's single-dose COVID-19 vaccine began shipping out today after it received emergency authorization over the weekend from the U.S. Food and Drug Administration.

That now makes three vaccines that are available in the U.S., along with the Pfizer-BioNTech and Moderna vaccines.

Health Canada has yet to approve the Johnson and Johnson shot, but gave the green light last week to a vaccine developed by AstraZeneca and the University of Oxford.

MORE International ARTICLES

FDA approves first COVID-19 drug: antiviral remdesivir

FDA approves first COVID-19 drug: antiviral remdesivir
The drug, which California-based Gilead Sciences Inc. is calling Veklury, cut the time to recovery by five days — from 15 days to 10 on average — in a large study led by the U.S. National Institutes of Health.

FDA approves first COVID-19 drug: antiviral remdesivir

Here we go again: Trump, Biden reprise debate duel

Here we go again: Trump, Biden reprise debate duel
Instead, they're bracing for another show of vintage Trump, one in which he'll seek to be heard even in spite of his muted microphone.

Here we go again: Trump, Biden reprise debate duel

Getting ready for the gong show: Trump v. Biden II

Getting ready for the gong show: Trump v. Biden II
It's the sequel to last month's debate horror show between Donald Trump and Joe Biden, an invective-laced 90 minutes that laid bare the depths to which political discourse can sink in an American election year.

Getting ready for the gong show: Trump v. Biden II

US overdose deaths appear to rise amid coronavirus pandemic

US overdose deaths appear to rise amid coronavirus pandemic
Davidson lost his job. He started staying home alone in his apartment near Georgetown, Kentucky — depressed and yearning for his recovery support group that had stopped gathering in person, said his cousin Melanie Wyatt.

US overdose deaths appear to rise amid coronavirus pandemic

Pfizer: Mid-November earliest it can seek virus vaccine OK

Pfizer: Mid-November earliest it can seek virus vaccine OK
Another leading U.S. contender, Moderna Inc., previously announced the earliest it could seek authorization of its own vaccine would be Nov. 25.

Pfizer: Mid-November earliest it can seek virus vaccine OK

UN: Europe's pandemic restrictions are absolutely necessary

UN: Europe's pandemic restrictions are absolutely necessary
In a meda briefing on Thursday, Dr. Hans Kluge warned that even more drastic steps might be needed in such “unprecedented times.”

UN: Europe's pandemic restrictions are absolutely necessary